IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RAVIGLIONE, MARIO CARLO BATTISTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.660
NA - Nord America 5.323
AS - Asia 5.175
SA - Sud America 775
AF - Africa 364
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.350
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.906
GB - Regno Unito 1.746
CN - Cina 1.648
IT - Italia 1.520
SG - Singapore 1.304
BR - Brasile 504
HK - Hong Kong 501
DE - Germania 491
RU - Federazione Russa 435
VN - Vietnam 397
FR - Francia 319
IN - India 285
SE - Svezia 275
BD - Bangladesh 236
CA - Canada 213
IE - Irlanda 209
ID - Indonesia 199
MX - Messico 158
FI - Finlandia 125
NL - Olanda 121
TR - Turchia 99
JP - Giappone 85
KR - Corea 85
ES - Italia 79
AR - Argentina 63
ZA - Sudafrica 61
PE - Perù 51
AU - Australia 49
ET - Etiopia 46
PK - Pakistan 46
UA - Ucraina 44
PL - Polonia 43
TW - Taiwan 41
CI - Costa d'Avorio 40
EC - Ecuador 39
TH - Thailandia 38
CL - Cile 35
CO - Colombia 35
DK - Danimarca 35
CH - Svizzera 33
NG - Nigeria 33
BE - Belgio 32
GR - Grecia 32
PH - Filippine 31
IQ - Iraq 30
AT - Austria 29
VE - Venezuela 28
MA - Marocco 24
PT - Portogallo 23
SA - Arabia Saudita 23
EG - Egitto 21
IR - Iran 21
KE - Kenya 20
MY - Malesia 19
DZ - Algeria 18
MZ - Mozambico 16
NO - Norvegia 12
RO - Romania 12
TN - Tunisia 12
JO - Giordania 11
TZ - Tanzania 11
ZM - Zambia 11
CZ - Repubblica Ceca 9
IL - Israele 9
KZ - Kazakistan 9
AE - Emirati Arabi Uniti 8
EU - Europa 8
HN - Honduras 8
LK - Sri Lanka 8
GH - Ghana 7
UY - Uruguay 7
UZ - Uzbekistan 7
PY - Paraguay 6
QA - Qatar 6
SN - Senegal 6
BO - Bolivia 5
CR - Costa Rica 5
LU - Lussemburgo 5
MN - Mongolia 5
NP - Nepal 5
PA - Panama 5
SV - El Salvador 5
BF - Burkina Faso 4
CM - Camerun 4
JM - Giamaica 4
LT - Lituania 4
SC - Seychelles 4
BG - Bulgaria 3
BH - Bahrain 3
BS - Bahamas 3
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
MG - Madagascar 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UG - Uganda 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
Totale 17.297
Salva come PNG Salva come JPEG
Città #
Southend 1.442
Singapore 662
Ashburn 554
Hong Kong 426
Milan 405
Fairfield 338
San Jose 291
Beijing 286
Dallas 261
Chandler 234
Council Bluffs 202
Frankfurt am Main 201
Princeton 185
Dublin 177
Seattle 177
Woodbridge 175
Wilmington 159
Los Angeles 129
Houston 120
Ann Arbor 117
Jakarta 113
Santa Clara 112
Dong Ket 110
Cambridge 109
Rome 107
Lauterbourg 101
New York 99
Ho Chi Minh City 93
Bengaluru 89
Helsinki 89
Munich 88
Buffalo 82
Guangzhou 81
Moscow 75
Des Moines 69
Montréal 65
Boardman 62
Hefei 59
Mcallen 56
Nanjing 55
Phoenix 54
Shanghai 54
Hanoi 52
São Paulo 50
Hanover 45
Naples 43
Tokyo 41
London 40
Seoul 40
Toronto 40
Abidjan 39
Redwood City 38
Menlo Park 36
Columbus 33
Jinan 33
Istanbul 32
San Diego 32
Washington 32
Bologna 29
Chicago 29
Cangzhou 28
Florence 28
Turin 28
Wuhan 28
Warsaw 27
Shenyang 26
Dearborn 25
Tianjin 25
Athens 24
Hangzhou 24
Nuremberg 24
Addis Ababa 23
Lima 23
Rio de Janeiro 23
Central District 22
Santiago 22
The Dalles 22
Ottawa 21
Taipei 21
Vienna 21
Atlanta 19
Bangkok 19
Berlin 19
Shenzhen 19
Montreal 18
Monza 18
Bogotá 17
Brussels 17
Chennai 17
Lappeenranta 17
Catania 16
Changsha 16
Padova 16
Silver Spring 16
Sydney 16
Belém 15
Buenos Aires 15
Madrid 15
Nairobi 15
Boston 14
Totale 9.866
Salva come PNG Salva come JPEG
Nome #
Zoonotic tuberculosis in human beings caused by Mycobacterium bovis -- call for action 2.271
Profilassi della polmonite da Pneumocystis Carinii con Trimetoprim-Sulfametossazolo intermittente 708
A new world health era 540
Tuberculosis makes it onto the international political agenda for health…finally 520
Ending infectious diseases in the era of the Sustainable Development Goals 360
Digital health for the end TB strategy : developing priority products and making them work 322
Detection of human papillomavirus in fresh and dried urine through an automated system for cervical cancer screening in low‐ and middle‐income countries 321
null 310
Evidence of SARS-CoV-2 RNA in an Oropharyngeal Swab Specimen, Milan, Italy, Early December 2019 294
Characteristics and clinical implications of carbapenemase-producing klebsiella pneumoniae colonization and infection, Italy 287
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 253
Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010 245
Digital health to end tuberculosis in the Sustainable Development Goals era: Achievements, evidence and future perspectives 218
Global Health Essentials 212
Latent tuberculosis screening and treatment among asylum seekers: A mixed-methods study 205
Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions 204
125 years after Robert Koch’s discovery of the tubercle bacillus : the new XDR-TB threat. Is science enough to tackle the epidemic? 197
Translational Research for Tuberculosis Elimination : Priorities, Challenges, and Actions 192
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones : results from a multicountry surveillance project 191
Agrofood System and Human Health 187
Molecular Evidence for SARS-CoV-2 in Samples Collected From Patients With Morbilliform Eruptions Since Late Summer 2019 in Lombardy, Northern Italy 181
Molecular evidence for SARS-CoV-2 in samples collected from patients with morbilliform eruptions since late 2019 in Lombardy, northern Italy 179
Stigma at the time of the COVID-19 pandemic 173
Twenty years of global surveillance of antituberculosis-drug resistance 173
The impact of COVID-19 hospitalizations on nursing home admissions: a regional insight into long-term care and public health 172
Improving the TB case management: The International Standards for Tuberculosis Care 172
The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic 170
The neglected role of faith-based organizations in prevention and control of COVID-19 in Africa 166
COVID-19 vaccines: Evidence, challenges and the future 162
Serological investigation of SARS-CoV-2 infection in patients with suspect measles, 2017-2022 156
Tuberculosis 2015 : burden, challenges and strategy for control and elimination 156
Clinical and operational value of the extensively drug-resistant tuberculosis definition 155
Political rationale, aims, and outcomes of health-related high-level meetings and special sessions at the UN General Assembly: A policy research observational study 153
Epidemiologia e prevenzione delle malattie trasmissibili: parte speciale 148
The Internet of Things to come : digital technologies and the End TB Strategy 147
Integrating health into the European Union Migrant and Asylum Pact: a call to action 147
HERA : a new era for health emergency preparedness in Europe? 144
Harnessing the Power of Data to Guide Local Action and End Tuberculosis 143
Mandatory tuberculosis case notification in high tuberculosis-incidence countries : policy and practice 143
Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis 141
Waiting for the truth: is reluctance in accepting an early origin hypothesis for SARS-CoV-2 delaying our understanding of viral emergence? 140
Elective Courses in Global Surgery for Undergraduate Medical Students: A Narrative Review and a Proposal for European Universities 138
Tuberculosis elimination : theory and practice in Europe 138
Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital 138
Association of tuberculosis risk with the degree of tuberculin reaction in HIV-infected patients 137
Extensively drug-resistant tuberculosis, Italy and Germany 136
Global ecological analysis of COVID-19 mortality and comparison between “the East” and “the West” 133
Towards tuberculosis elimination: an action framework for low-incidence countries 130
The COVID-19 pandemic preparedness ... or lack thereof: from China to Italy 130
Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by crossborder migration 129
European union standards for tuberculosis care 124
Impact of socio-economic factors on Tuberculosis treatment outcomes in north-eastern Uganda: a mixed methods study 124
Target regimen profiles for treatment of tuberculosis: A WHO document 122
Extensively drug-resistant tuberculosis, Italy and Germany 120
‘One Health´ approach to end zoonotic TB 120
Celebrating World Tuberculosis Day at the time of COVID-19 119
Rapid molecular TB diagnosis : Evidence, policy making and global implementation of Xpert MTB/RIF 119
Preventive therapy for tuberculosis in HIV-infected persons: Analysis of policy options based on tuberculin status and CD4+cell count 118
Global tuberculosis targets and milestones set for 2016-2035 : definition and rationale 118
Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance 117
Ensuring rational introduction and responsible use of new TB tools : outcome of an ERS multisector consultation 113
Targeting harmful use of alcohol for prevention and treatment of tuberculosis: A call for action 113
Beyond UHC: Monitoring Health and Social Protection Coverage in the Context of Tuberculosis Care and Prevention 113
Migrants’ health : building migrant-sensitive health systems 111
Towards the development of EU/EEA Standards for Tuberculosis Care (ESTC) 107
Aiming for zero tuberculosis transmission in low-burden countries 106
Evolution of programmatic definitions used in tuberculosis prevention and care 106
Latent Tuberculosis Infection Treatment Completion while Shifting Prescription from Isoniazid-Only to Rifampicin-Containing Regimens : A Two-Decade Experience in Milan, Italy 106
The role of eHealth and mHealth in tuberculosis and tobacco control: A WHO/ERS consultation 105
Drug resistant tuberculosis in Italy through a global health lens 105
WHO's new end TB strategy 102
Synergising one health and environmental, social, and governance (ESG) standards: A scoping review 101
Balancing Equity and Global Health Security Towards a Fair and Effective Pandemic Agreement 100
Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy 98
The WHO policy package to combat antimicrobial resistance 97
Tuberculosis management in Europe 97
A Multisectoral Approach to Tuberculosis Control and Elimination in the Era of the United Nations Sustainable Development Goals 97
Assessment of worldwide tuberculosis control 96
Migrant health and tuberculosis 82
How human immunodeficiency virus voluntary testing can contribute to tuberculosis control 82
Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian federation 81
Tuberculosis trends in Eastern Europe and the former USSR 81
Build back stronger universal health coverage systems after the COVID-19 pandemic: the need for better governance and linkage with universal social protection 80
Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: Outbreak from a smear-positive healthcare worker 79
Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2 77
Funnel-based antimicrobial resistance monitoring in Italy: the FUN-IT study 74
Tuberculosis treatment in developing nations 74
Rebalancing the global battle against tuberculosis 74
Specialist Healthcare Intervention and Follow-up Trends in Post-Acute COVID-19 Hospitalization as Compared to Other Respiratory Infections 73
Epidemiology of tuberculosis 73
Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country 71
Tuberculosis 69
Increasing transparency in partnerships for health - Introducing the Green Light Committee 67
How human immunodeficiency virus voluntary testing can contribute to tuberculosis control 66
Dynamics and control of the global tuberculosis epidemic 66
Helicobacter pylori infection in patients with acquired immune deficiency syndrome 65
Tuberculosis control, and the where and why of artificial intelligence 65
The TB epidemic from 1992 to 2002 62
Direct observation for tuberculosis treatment [4] 61
Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB 60
Totale 17.223
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.863
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.863
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021247 0 0 0 0 0 0 0 0 0 0 0 247
2021/20221.611 159 145 176 97 102 117 133 131 124 110 91 226
2022/20231.656 165 108 124 115 202 283 94 118 143 61 178 65
2023/20241.719 78 118 128 130 349 95 117 120 78 99 184 223
2024/20253.151 173 246 125 258 194 212 205 321 246 229 300 642
2025/20265.888 520 416 673 481 518 419 656 294 669 408 526 308
Totale 18.023